Duff, Ackerman & Goodrich

Duff, Ackerman & Goodrich, operating as DAG Ventures, is a venture capital firm headquartered in Palo Alto, California. Founded in 1991, the firm specializes in mid-to-late-stage investments across the technology, energy, and life sciences sectors. DAG Ventures is known for its 'sidecar' investment strategy, where it partners with leading early-stage venture capital firms to provide follow-on growth capital to promising companies. While not a drug developer itself, the firm has been a significant investor in numerous biotechnology and healthcare companies, supporting them through clinical development and commercialization. Their portfolio includes a wide range of successful exits in the healthcare and medical technology space.